Molzym has been committed to innovative solutions for biological research and diagnosis of infectious diseases. Their developmental efforts are particularly focused on new processes enabling and facilitating the molecular diagnosis of diseases caused by bacteria and fungi.
MolYsis, are dedicated to the targeted isolation of pathogen DNA from a variety of clinical samples, including blood culture, whole blood, CSF, BAL, joint aspirates, tissues and other operated material. Ultra-pure, DNA-free PCR reagents and mastermixes allow for the precise detection and monitoring of infectious diseases in humans and animal models.
The latest development in 2016 from Molzym, the SelectNA Plus, is an instrument for the fully automated extraction of pathogen DNA from all clinical samples. SelectNA Plus combines highest technical advances with demands for contamination-free and low-hands-on processing of samples for highest detection sensitivity of pathogens.